Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 mars 2026 06h03 HE | Source: Arch Biopartners

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, March 30, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has arranged a non-brokered private placement...
20 mars 2026 07h05 HE | Source: Arch Biopartners

Arch Biopartners Announces St. Michael’s Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

TORONTO, March 20, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that St. Michael’s Hospital (SMH), part of Unity...
22 mai 2018 10h10 HE | Source: T1D Exchange

CORRECTING and REPLACING – Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge

In a release issued under the same headline earlier today by T1D Exchange please note that in the third paragraph of the release the name of the Protomer Technologies Founder and CEO should by Alborz...
22 mai 2018 07h00 HE | Source: T1D Exchange

Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge

BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Protomer Technologies of Pasadena, CA, will receive $50,000 in cash and up to $150,000 of in-kind support as the winner of the 2018 Diabetes Innovation...
16 mai 2018 09h00 HE | Source: T1D Exchange

Media Advisory: Monday, May 21 - 2018 Diabetes Innovation Challenge Pitch Off

ROYAL SONESTA BOSTON3:00 PM – 5:00 PM $250,000 IN CASH AND IN-KIND PRIZES TO BE AWARDED BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Ten finalists, all academic researchers and early stage companies,...